Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body.
The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. Beyond providing a general analysis and forecast for each device segment in different global regions from 2013–2022, this report offers a more detailed approach by assessing the adoption patterns of the different biopsy procedure types for specific cancer indications in specific geographies. This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers.
About The Report
US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India
Request Sample Pages